Extended‐release naltrexone/bupropion and liver health: pooled, post‐hoc analysis from 4 RCTs

Diabetes Obesity and Metabolism ◽

10.1111/dom.14284 ◽

2020 ◽

Author(s):

Harpreet S. Bajaj ◽

Melonie Burrows ◽

Jessica Blavignac ◽

Emilia Paron ◽

Fernando Camacho ◽

...

Keyword(s):

Extended Release ◽

Post Hoc Analysis ◽

Liver Health ◽

Post Hoc

Download Full-text

Review for "Extended‐release naltrexone/bupropion and liver health: pooled, post‐hoc analysis from 4 RCTs"

10.1111/dom.14284/v1/review3 ◽

2020 ◽

Author(s):

Kristy Robledo

Keyword(s):

Extended Release ◽

Post Hoc Analysis ◽

Liver Health ◽

Post Hoc

Download Full-text

Review for "Extended‐release naltrexone/bupropion and liver health: pooled, post‐hoc analysis from 4 RCTs"

10.1111/dom.14284/v1/review2 ◽

2020 ◽

Author(s):

John Brennan

Keyword(s):

Extended Release ◽

Post Hoc Analysis ◽

Liver Health ◽

Post Hoc

Download Full-text

Review for "Extended‐release naltrexone/bupropion and liver health: pooled, post‐hoc analysis from 4 RCTs"

10.1111/dom.14284/v1/review1 ◽

2020 ◽

Author(s):

Megha Poddar

Keyword(s):

Extended Release ◽

Post Hoc Analysis ◽

Liver Health ◽

Post Hoc

Download Full-text

Decision letter for "Extended‐release naltrexone/bupropion and liver health: pooled, post‐hoc analysis from 4 RCTs"

10.1111/dom.14284/v1/decision1 ◽

2020 ◽

Keyword(s):

Extended Release ◽

Post Hoc Analysis ◽

Liver Health ◽

Post Hoc

Download Full-text

Review for "Extended‐release naltrexone/bupropion and liver health: pooled, post‐hoc analysis from 4 RCTs"

10.1111/dom.14284/v2/review2 ◽

2020 ◽

Keyword(s):

Extended Release ◽

Post Hoc Analysis ◽

Liver Health ◽

Post Hoc

Download Full-text

Review for "Extended‐release naltrexone/bupropion and liver health: pooled, post‐hoc analysis from 4 RCTs"

10.1111/dom.14284/v2/review1 ◽

2020 ◽

Keyword(s):

Extended Release ◽

Post Hoc Analysis ◽

Liver Health ◽

Post Hoc

Download Full-text

Author response for "Extended‐release naltrexone/bupropion and liver health: pooled, post‐hoc analysis from 4 RCTs"

10.1111/dom.14284/v2/response1 ◽

2020 ◽

Author(s):

Harpreet S. Bajaj ◽

Melonie Burrows ◽

Jessica Blavignac ◽

Emilia Paron ◽

Fernando Camacho ◽

...

Keyword(s):

Extended Release ◽

Author Response ◽

Post Hoc Analysis ◽

Liver Health ◽

Post Hoc

Download Full-text

Decision letter for "Extended‐release naltrexone/bupropion and liver health: pooled, post‐hoc analysis from 4 RCTs"

10.1111/dom.14284/v2/decision1 ◽

2020 ◽

Keyword(s):

Extended Release ◽

Post Hoc Analysis ◽

Liver Health ◽

Post Hoc

Download Full-text

Effects of Dalfampridine Extended-release Tablets on 6-minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-blind, Placebo-controlled Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2015.10.014 ◽

2015 ◽

Vol 37 (12) ◽

pp. 2780-2787 ◽

Cited By ~ 16

Author(s):

Angela Applebee ◽

Andrew D. Goodman ◽

Angeli S. Mayadev ◽

Francois Bethoux ◽

Myla D. Goldman ◽

...

Keyword(s):

Multiple Sclerosis ◽

Extended Release ◽

Controlled Trial ◽

Walk Distance ◽

Double Blind ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

Post Hoc ◽

Minute Walk Distance ◽

Minute Walk

Download Full-text

Cognitive performance of patients with opioid use disorder transitioned to extended-release injectable naltrexone from buprenorphine: Post hoc analysis of exploratory results of a phase 3 randomized controlled trial

Addictive Behaviors ◽

10.1016/j.addbeh.2020.106538 ◽

2020 ◽

Vol 111 ◽

pp. 106538

Author(s):

Thomas Kosten ◽

Efrat Aharonovich ◽

Narinder Nangia ◽

Abigail Zavod ◽

Sarah C. Akerman ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Cognitive Performance ◽

Extended Release ◽

Controlled Trial ◽

Opioid Use Disorder ◽

Opioid Use ◽

Phase 3 ◽

Post Hoc Analysis ◽

Randomized Controlled ◽

Post Hoc

Download Full-text